Furthermore, the significant correlation between MCT2 and IL-1β/LCN2 expressions in clinical breast cancer specimens supports the role of an MCT2-mediated oncogenic pathway in breast cancer progression. The gene discussed is SLC16A7; the disease is breast carcinoma.